RESUMO
MicroRNAs (miRNAs) provide a fundamental layer of regulation in cells. miRNAs act posttranscriptionally through complementary base-pairing with the 3'-UTR of a target mRNA, leading to mRNA degradation and translation arrest. The likelihood of forming a valid miRNA-target duplex within cells was computationally predicted and experimentally monitored. In human cells, the miRNA profiles determine their identity and physiology. Therefore, alterations in the composition of miRNAs signify many cancer types and chronic diseases. In this chapter, we introduce online functional tools and resources to facilitate miRNA research. We start by introducing currently available miRNA catalogs and miRNA-gateway portals for navigating among different miRNA-centric online resources. We then sketch several realistic challenges that may occur while investigating miRNA regulation in living cells. As a showcase, we demonstrate the utility of miRNAs and mRNAs expression databases that cover diverse human cells and tissues, including resources that report on genetic alterations affecting miRNA expression levels and alteration in binding capacity. Introducing tools linking miRNAs with transcription factor (TF) networks reveals miRNA regulation complexity within living cells. Finally, we concentrate on online resources that analyze miRNAs in human diseases and specifically in cancer. Altogether, we introduce contemporary, selected resources and online tools for studying miRNA regulation in cells and tissues and their utility in health and disease.
Assuntos
MicroRNAs , Humanos , Regulação da Expressão Gênica , MicroRNAs/genética , MicroRNAs/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Fatores de Transcrição/metabolismo , Bases de Dados FactuaisRESUMO
Endometriosis is a condition characterized by implants of endometrial tissues into extrauterine sites, mostly within the pelvic peritoneum. The prevalence of endometriosis is under-diagnosed and is estimated to account for 5-10% of all women of reproductive age. The goal of this study was to develop a model for endometriosis based on the UK-biobank (UKB) and re-assess the contribution of known risk factors to endometriosis. We partitioned the data into those diagnosed with endometriosis (5924; ICD-10: N80) and a control group (142,723). We included over 1000 variables from the UKB covering personal information about female health, lifestyle, self-reported data, genetic variants, and medical history prior to endometriosis diagnosis. We applied machine learning algorithms to train an endometriosis prediction model. The optimal prediction was achieved with the gradient boosting algorithms of CatBoost for the data-combined model with an area under the ROC curve (ROC-AUC) of 0.81. The same results were obtained for women from a mixed ethnicity population of the UKB (7112; ICD-10: N80). We discovered that, prior to being diagnosed with endometriosis, affected women had significantly more ICD-10 diagnoses than the average unaffected woman. We used SHAP, an explainable AI tool, to estimate the marginal impact of a feature, given all other features. The informative features ranked by SHAP values included irritable bowel syndrome (IBS) and the length of the menstrual cycle. We conclude that the rich population-based retrospective data from the UKB are valuable for developing unified machine learning endometriosis models despite the limitations of missing data, noisy medical input, and participant age. The informative features of the model may improve clinical utility for endometriosis diagnosis.
RESUMO
The COVID-19 pandemic that started in China has spread within 3 months to the entire globe. We tested the hypothesis that the vaccination against tuberculosis by Bacille Calmette-Guérin vaccine (BCG) correlates with a better outcome for COVID-19 patients. Our analysis covers 55 countries complying with predetermined thresholds on the population size and number of deaths per million (DPM). We found a strong negative correlation between the years of BCG administration and the DPM along with the progress of the pandemic, corroborated by permutation tests. The results from multivariable regression tests with 23 economic, demographic, health-related, and pandemic restriction-related quantitative properties, substantiate the dominant contribution of BCG years to the COVID-19 outcomes. The analysis of countries according to an age-group partition reveals that the strongest correlation is attributed to the coverage in BCG vaccination of the young population (0-24 years). Furthermore, a strong correlation and statistical significance are associated with the degree of BCG coverage for the most recent 15 years, but no association was observed in these years for other broadly used vaccination protocols for measles and rubella. We propose that BCG immunization coverage, especially among the most recently vaccinated population, contribute to attenuation of the spread and severity of the COVID-19 pandemic.